Meaning
A contractual arrangement in a purchase agreement determines which party is responsible for proposing and executing remedies required by government agencies to clear a merger. This regulatory remedy allocation defines who pays for the divestitures or accepts the operational limitations necessary to secure regulatory approval.
Risk Apportionment
The division of responsibility ranges from the buyer agreeing to any demand to the seller agreeing to divest certain non-core business units. It reflects the relative bargaining power of each party and the perceived level of antitrust risk associated with the transaction. A seller with high leverage will demand that the buyer commit to a clean-up divestiture, requiring the buyer to sell off overlapping product lines to guarantee regulatory approval.
Execution Limit
Specific caps are often established to limit the financial or operational sacrifices either party must make to save the transaction. If the required remedies exceed these caps, either the buyer or the seller may have the right to terminate the transaction.
Dispute Resolution
Disagreements on the adequacy or speed of proposed remedies are usually resolved through accelerated arbitration procedures to avoid deal expiration. This structured approach helps prevent either party from strategically dragging out the regulatory process to exit the contract.
